Yan Geng Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

4/2024	The effect of food on the pharmacokinetics of Sutetinib maleate capsule, an irreversible EGFR tyrosine kinase inhibitor, in healthy Chinese subjects.
9/2021	Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
7/2005	[Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Geng Research Topics

Disease

60	Neoplasms (Cancer) 04/2024 - 12/2003
13	Carcinogenesis 04/2024 - 12/2003
13	Inflammation (Inflammations) 02/2024 - 02/2015
12	Rheumatoid Arthritis 04/2024 - 10/2012
10	Fibrosis (Cirrhosis) 06/2024 - 01/2014
10	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 07/2009
9	Neoplasm Metastasis (Metastasis) 11/2021 - 09/2008
8	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 03/2016
6	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2018
6	Breast Neoplasms (Breast Cancer) 10/2020 - 08/2002
5	Lung Neoplasms (Lung Cancer) 12/2023 - 04/2008
4	COVID-19 04/2024 - 11/2020
4	Colitis 02/2024 - 01/2016
4	Body Weight (Weight, Body) 02/2024 - 08/2009
4	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2017
4	Heat Stroke (Heatstroke) 01/2023 - 02/2015
4	Carcinoma (Carcinomatosis) 01/2023 - 01/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 07/2005
3	Infections 04/2024 - 04/2018
3	Adenocarcinoma of Lung 03/2024 - 01/2023
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2013
3	Wounds and Injuries (Trauma) 08/2023 - 02/2015
3	Adenocarcinoma 01/2023 - 07/2011
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2022 - 06/2019
3	Thrombocytopenia (Thrombopenia) 12/2022 - 12/2018
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2022 - 02/2015
3	Synovitis 03/2022 - 08/2014
3	Pain (Aches) 01/2022 - 10/2015
3	Ulcerative Colitis 12/2021 - 12/2010
3	Insulin Resistance 04/2021 - 12/2019
3	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024 - 12/2022
2	Fatigue 04/2024 - 07/2022
2	Triple Negative Breast Neoplasms 12/2023 - 10/2020
2	Asthma (Bronchial Asthma) 11/2023 - 08/2021
2	Liver Neoplasms (Liver Cancer) 11/2023 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 01/2022
2	Sarcoma (Soft Tissue Sarcoma) 06/2023 - 01/2022
2	Heart Diseases (Heart Disease) 05/2023 - 11/2020
2	Ischemic Stroke 01/2023 - 01/2022
2	Obesity 10/2022 - 01/2021
2	Hemorrhage 10/2022 - 01/2009
2	Nephritis 02/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2003
10	CyclinsIBA 01/2022 - 12/2003
8	Phosphotransferases (Kinase)IBA 01/2022 - 01/2006
7	Interleukin-6 (Interleukin 6)IBA 01/2024 - 07/2005
7	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2009
6	MicroRNAs (MicroRNA)IBA 01/2023 - 04/2016
5	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2019
5	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2018
5	Therapeutic UsesIBA 11/2023 - 12/2010
5	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2023 - 01/2017
5	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 07/2011
5	Cyclin D1IBA 01/2014 - 08/2004
4	LipidsIBA 02/2024 - 08/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 01/2016
4	UbiquitinIBA 10/2023 - 01/2010
4	Cyclin EIBA 01/2021 - 08/2007
4	GenisteinIBA 03/2017 - 10/2005
3	Neutralizing AntibodiesIBA 04/2024 - 02/2015
3	Dextran SulfateIBA 02/2024 - 01/2016
3	InterleukinsIBA 01/2024 - 01/2016
3	ChitosanIBA 12/2023 - 10/2022
3	Monoclonal AntibodiesIBA 11/2023 - 01/2022
3	InflammasomesIBA 02/2023 - 09/2015
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2019
3	Bleomycin (Blenoxane)FDA LinkGeneric 11/2022 - 02/2015
3	Interleukin-10 (Interleukin 10)IBA 12/2021 - 06/2019
3	CytokinesIBA 10/2021 - 02/2015
3	FollistatinIBA 01/2020 - 04/2013
3	Translationally-Controlled 1 Tumor ProteinIBA 10/2018 - 01/2010
3	rakicidinsIBA 05/2018 - 11/2014
3	Surface-Active Agents (Surfactants)IBA 11/2016 - 01/2006
3	Soybean Proteins (Soy Protein)IBA 05/2007 - 06/2005
3	Caseins (Casein)FDA Link 10/2005 - 12/2004
2	InterferonsIBA 04/2024 - 02/2016
2	COVID-19 VaccinesIBA 04/2024 - 01/2022
2	16S Ribosomal RNAIBA 03/2024 - 01/2023
2	AntioxidantsIBA 01/2024 - 09/2020
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2024 - 01/2017
2	AcidsIBA 01/2024 - 01/2020
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2023 - 01/2022
2	Hypoglycemic Agents (Hypoglycemics)IBA 11/2023 - 12/2021
2	AntibodiesIBA 11/2023 - 01/2019
2	Polysaccharides (Glycans)IBA 02/2023 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 04/2021
2	Messenger RNA (mRNA)IBA 01/2023 - 06/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 12/2018
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2021
2	N-methyladenosineIBA 01/2023 - 03/2020
2	GlucocorticoidsIBA 12/2022 - 01/2021
2	EndotoxinsIBA 10/2022 - 11/2012
2	LipopolysaccharidesIBA 10/2022 - 01/2017
2	PowdersIBA 07/2022 - 09/2020

Therapy/Procedure

27	Therapeutics 04/2024 - 12/2010
5	Drug Therapy (Chemotherapy) 03/2024 - 03/2012
3	Immunotherapy 11/2021 - 09/2019
2	Intraperitoneal Injections 01/2023 - 01/2013
2	Fecal Microbiota Transplantation 01/2023 - 05/2022